Gratis Versand ab 16,99 €. Mehr Infos.
Bookbot

Drugs and the Pharmaceutical Sciences - 143: Generic Drug Product Development

Solid Oral Dosage Forms

Parameter

  • 381 Seiten
  • 14 Lesestunden

Mehr zum Buch

Keeping pace with the latest technologies in the field, this guide describes the development of solid oral generic drug products from project initiation to market approval. Focusing on immediate-release and modified-release dosage forms, the book collects in-depth discussions from more than 30 noted specialists on topics such as quality control, experimental formulation, pharmaceutical ingredients, and bioequivalence, and considers key elements in the formulation of generic drug products including the availability of raw materials, chemical purity. It also highlights constraints in generic drug development that differ from the formulation design of a brand name pharmaceutical product.

Buchkauf

Drugs and the Pharmaceutical Sciences - 143: Generic Drug Product Development, Leon Shargel, Isadore Kanfer

Sprache
Erscheinungsdatum
2004
product-detail.submit-box.info.binding
(Hardcover),
Buchzustand
Beschädigt
Preis
38,57 €inkl. MwSt.

Lieferung

  • Gratis Versand ab 16,99 € in ganz Deutschland! Mehr Infos.

Zahlungsmethoden

Keiner hat bisher bewertet.Abgeben

Titel
Drugs and the Pharmaceutical Sciences - 143: Generic Drug Product Development
Untertitel
Solid Oral Dosage Forms
Sprache
Englisch
Verlag
CRC Press
Erscheinungsdatum
2004
Einband
Hardcover
Seitenzahl
381
ISBN10
0824754603
ISBN13
9780824754600
Reihe
Beschreibung
Keeping pace with the latest technologies in the field, this guide describes the development of solid oral generic drug products from project initiation to market approval. Focusing on immediate-release and modified-release dosage forms, the book collects in-depth discussions from more than 30 noted specialists on topics such as quality control, experimental formulation, pharmaceutical ingredients, and bioequivalence, and considers key elements in the formulation of generic drug products including the availability of raw materials, chemical purity. It also highlights constraints in generic drug development that differ from the formulation design of a brand name pharmaceutical product.